全球粪便钙卫蛋白检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计粪便钙卫蛋白检测市场将从 2025 年的 51.4 亿美元成长到 2034 年的 141.2 亿美元，2026 年至 2034 年的复合年增长率为 11.89%。

随着医疗机构日益重视胃肠道疾病的早期检测和监测，粪便钙卫蛋白（CHL）检测市场正蓬勃发展。钙卫蛋白是一种肠道发炎生物标记物，越来越多地用于诊断发炎性肠道疾病（IBD）、克隆氏症、溃疡性大肠炎和其他疾病。随着全球慢性胃肠道疾病负担的加重，对可靠、非侵入性检测方法的需求预计将加速成长。

技术进步正在提高诊断的准确性和效率。就地检验盒能够快速提供检测结果，有助于提高患者的治疗依从性，并为制定合适的治疗方案提供支援。自动化免疫检测和酵素连结免疫吸附试验（ELISA）平台简化了检查室操作，而数位资料管理则实现了检测结果与电子健康记录的整合。这些进步正在改善全球医疗保健系统的临床疗效和营运效率。

未来市场扩张将受个人化医疗和预防医学的影响。随着临床医生越来越多地采用基于生物标记的疾病管理方法，粪便钙卫蛋白检测将在减少大肠镜检查等侵入性操作方面发挥关键作用。新兴经济体预计将迎来显着成长，这得益于公众意识的提高和医疗基础设施的不断改善。创新和可近性的提升推动了此检测方法的应用，使其成为全球诊断领域的重要组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球粪便钙卫蛋白检测市场：依检测方法划分

• 市场分析、洞察与预测
• 酵素免疫分析法
• 酵素萤光免疫分析
• 定量层析法

第五章：全球粪便钙卫蛋白检测市场：依应用划分

• 市场分析、洞察与预测
• 发炎性肠道疾病
• 结肠癌
• 其他的

第六章：全球粪便钙卫蛋白检测市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 诊断检查室
• 学术研究机构

第七章 全球粪便钙卫蛋白检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Epitope Diagnostics Inc
  • Hycult Biotech
  • Actim, Eagle BiosciencesInc
  • Operon
  • Svar Life Science
  • BA1/4Hlmann
  • DRG International Inc
  • ALPCO
  • Diazyme Laboratories

The Faecal Calprotectin Testing Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.14 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The faecal calprotectin testing market is gaining momentum as healthcare providers emphasize early detection and monitoring of gastrointestinal diseases. Calprotectin, a biomarker of intestinal inflammation, is increasingly used in diagnosing conditions such as inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. With the global burden of chronic digestive disorders on the rise, demand for reliable, non-invasive testing methods is expected to accelerate.

Technological progress is enhancing diagnostic accuracy and efficiency. Point-of-care testing kits are enabling rapid results, improving patient compliance, and supporting timely treatment decisions. Automated immunoassays and ELISA platforms are streamlining laboratory workflows, while digital data management is integrating test results with electronic health records. These advancements are improving both clinical outcomes and operational efficiency for healthcare systems worldwide.

Future market expansion will be shaped by personalized medicine and preventive healthcare. As clinicians increasingly adopt biomarker-based approaches for disease management, faecal calprotectin testing will play a crucial role in reducing invasive procedures such as colonoscopy. Emerging economies are expected to witness significant growth, supported by rising awareness and expanding healthcare infrastructure. With innovation and accessibility driving adoption, this testing market is positioned as a vital component of the global diagnostic landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Assay

• Enzyme-linked Immunosorbent Assay
• Enzyme Fluroimmunoassay
• Quantitative Immunochromatography

By Application

• Inflammatory Bowel Disease
• Colorectal Cancer
• Others

By End-use

• Hospitals And Clinics
• Diagnostic Laboratories
• Academic And Research Institutes

COMPANIES PROFILED

• Epitope Diagnostics Inc, Hycult Biotech, Actim, Eagle Biosciences, Inc, Operon, Svar Life Science, Bhlmann, DRG International Inc, ALPCO, Diazyme Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY ASSAY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Assay
• 4.2. Enzyme-linked Immunosorbent Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzyme Fluroimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Quantitative Immunochromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Inflammatory Bowel Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Assay
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Assay
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Assay
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Assay
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Assay
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FAECAL CALPROTECTIN TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Epitope Diagnostics Inc
  • 9.2.2 Hycult Biotech
  • 9.2.3 Actim, Eagle BiosciencesInc
  • 9.2.4 Operon
  • 9.2.5 Svar Life Science
  • 9.2.6 BA1/4Hlmann
  • 9.2.7 DRG International Inc
  • 9.2.8 ALPCO
  • 9.2.9 Diazyme Laboratories